Medical robotics is an emerging field that is rapidly gaining traction, and the medical robots market is projected to witness a moderate pace in the global market at a CAGR of 17.4% between 2022 and 2032. Medical Robots offer a variety of benefits over traditional medical procedures, including increased precision in diagnostics, improved patient safety and satisfaction, and greater cost efficiency.

Robotic surgical systems are capable of performing precise and accurate surgeries with minimal risk to the patient. In addition to improving the overall accuracy of surgeries, these systems can reduce operating times and post-operative recovery periods. For example, robotic-assisted laparoscopic surgery results in significantly less pain and fewer complications than traditional open abdominal surgeries.

Robots are also being used as assistants in pharmaceutical manufacturing processes for increased production accuracy and quality control. Automated dispensing robots help pharmacies accurately dispense medications quickly and correctly, reducing errors and providing better patient care. Additionally, robots have been increasingly utilized in clinical settings to help check vital signs or administer drugs.

The medical robotics market continues to grow as more organizations recognize the potential benefits this technology offers. Companies like Intuitive Surgical, Medtronic, Johnson & Johnson and Siemens continue to lead the way in developing innovative solutions that improve quality of life for both patients and healthcare providers alike.

How does Competition Influence the Medical Robots Market?

The latest research on Medical Robots Market by PMR suggests that the medical robots market’s competitive landscape exhibits a fragmented nature, with various competitors present.

Despite the presence of multiple companies, the medical robots market is moderately consolidated, as the majority of market demand is fulfilled by advanced solutions from major players.

Western partnerships to improve healthcare, domestic manufacturers’ creation of surgical robots, and many government collaborations with regional universities for research and development are all factors in the country’s growth and competitiveness. These businesses are relying on strategic collaboration activities to grow their market share and profit margins.

• Stryker Corporation (US) gained regulatory approval in Japan in 2020 for the MAKO robotic surgery system for partial knee replacement.
• Accuray (US) introduced the CyberKnife S7 System in 2020, a next-generation CyberKnife platform that offers advanced precision, real-time artificial intelligence (AI)-driven motion tracking, and synchronisation treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.
• Medicrea, a pioneer in the change of spinal surgery through artificial intelligence, predictive modelling, and patient-specific implants, was bought by Medtronic (Ireland) in 2020.
• Intuitive Surgical (US) gained FDA approval for the da Vinci Single-port Surgical System in 2019.
• Mobius Imaging, LLC (US) and Cardan Robotics were bought by Stryker Corporation (US) in 2019. (US). This acquisition adds superior imaging and robotics skills, as well as a strong product pipeline.

The post Exploring the Advancements and Opportunities in the Growing Medical Robots Market 2023 appeared first on Lake Shore Gazette.